These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 7905382)

  • 41. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of [14C]avitriptan in rats and humans.
    Marathe PH; Greene DS; Barbhaiya RH
    Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
    Wu WN; Masucci JA; Caldwell GW; Carson JR
    Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
    Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
    Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
    Ramji JV; Austin NE; Boyle GW; Chalker MH; Duncan G; Fairless AJ; Hollis FJ; McDonnell DF; Musick TJ; Shardlow PC
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic disposition of casopitant, a potent neurokinin-1 receptor antagonist, in mice, rats, and dogs.
    Miraglia L; Pagliarusco S; Bordini E; Martinucci S; Pellegatti M
    Drug Metab Dispos; 2010 Oct; 38(10):1876-91. PubMed ID: 20622044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
    Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
    Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans.
    Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C; Cui D; Potchoiba MJ; Butler T
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
    Emary WB; Toren PC; Mathews B; Huh K
    Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative metabolic disposition of oral doses of omeprazole in the dog, rat, and mouse.
    Hoffmann KJ; Renberg L; Olovson SG
    Drug Metab Dispos; 1986; 14(3):336-40. PubMed ID: 2872035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.